Cat.#: ACPP-1508
| Despition | I TAC Human Recombinant |
| SIZE | 5 µg |
| Purity | > 97.0% (SDS-PAGE) |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1309 | CCR5 Blocking Peptide (AC1309) | 250 µg | inquiry |
| ACPP-1820 | Rat CNTF Protein, His (AC1820) | 2 µg | inquiry |
| ACPP-1324 | Insulin Receptor Blocking Peptide (AC1324) | 250 µg | inquiry |
| ACPP-1204 | P2Y1 Blocking Peptide (AC1204) | 250 µg | inquiry |
| ACPP-1815 | Human HAAO Protein (AC1815) | 2 µg | inquiry |
| ACPP-1482 | Human FGFR1 Protein (AC1482) | 2 µg | inquiry |
| ACPP-1726 | Human Midkine Protein (AC1726) | 5 µg | inquiry |
| ACPP-1665 | Human CDK5 Protein (AC1665) | 5 µg | inquiry |
| ACPP-1164 | Synthetic Nanodisc Human GRPR Protein (AC1164) | 10 µg | inquiry |
| ACPP-1181 | Synthetic Nanodisc Human CX3CR1 Protein (AC1181) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.